Maricann Group (CNSX:MARI) Price Target Raised to $5.75

Posted by on Dec 2nd, 2024

Maricann Group (CNSX:MARI – Free Report) had its price objective lifted by BMO Capital Markets from $5.50 to $5.75 in a report published on Friday morning,BayStreet.CA reports.

Maricann Group Price Performance

Maricann Group has a twelve month low of $0.87 and a twelve month high of $3.60.

About Maricann Group

(Get Free Report)

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients.

Featured Stories

Receive News & Ratings for Maricann Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maricann Group and related companies with MarketBeat.com's FREE daily email newsletter.